SC clarifies scope of TRO on contraceptives
Last May 26, the Supreme Court finally released its Aug. 26, 2016 resolution clarifying that the temporary restraining order (TRO), issued on June 17, 2015, only covers Implanon and Implanon NXT, and was never meant to cover other contraceptives that are “unquestionably non-abortifacient.” The Court added that the TRO is deemed lifted once the Food and Drugs Administration (FDA) follows its ruling and provides an opportunity for the oppositors to comment on the registration of Implanon and Implanon NXT.
The Supreme Court maintained that the FDA must develop procedures for the screening, evaluation and approval of contraceptive drugs and devices; it also modified its August 2016 resolution by stating that the FDA decisions may be appealed to the Office of the President.
The Purple Ribbon for Reproductive Health views this recent modification as a means to a better end—another step forward in the implementation of sexual and reproductive health and rights (SRHR) policies at both national government and local government levels.
We urge the FDA to comply with the Supreme Court resolution immediately.
The Purple Ribbon for Reproductive Health urges stakeholders to strongly advocate for the implementation of the Responsible Parenthood and Reproductive Health (RH) Law. This landmark legislation not only provides access to family planning; it also institutionalizes programs for maternal healthcare, age-appropriate sexuality and reproductive health education, as well as provides funding for these programs.
The Purple Ribbon for Reproductive Health remains committed to and vigilant in pushing for the implementation of the RH Law and urges all Filipinos to assert their SRHR and to do their part in seeing this advocacy through.
PURPLE RIBBON FOR REPRODUCTIVE HEALTH
